NCT02514044View on ClinicalTrials.gov

Dextroamphetamine and tDCS to Improve the Fluency

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Stroke
Interventions
DRUG

Dexedrine

10 mg immediate release of Dexedrine

DEVICE

Active tDCS

1.5 mA tDCS anodal tDCS

BEHAVIORAL

Speech Therapy

60 min of speech therapy

DRUG

Placebo

DEVICE

Sham tDCS

Trial Locations (1)

77030

University of Texas Health Science Center, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02514044 - Dextroamphetamine and tDCS to Improve the Fluency | Biotech Hunter | Biotech Hunter